Scoping Review: Efektivitas Pemberian Siprofloksasin Topikal pada Pasien Otitis Media Akut

Sucia Rosa, Ratna Dewi Indi Astuti, Lelly Yuniarti

Abstract


Abstract. Acute otitis media (AOM) is inflammation of the middle ear that lasts up to three weeks. Streptococcus pneumoniae and Haemophilus influenza cause about 50-90% of cases of AOM. Topical ciprofloxacin is often used to treat AOM in perforated stadiums. The aim of this study was to analyze the effectiveness of topical ciprofloxacin in patients with AOM. This research is a Scoping Review, by searching for articles from the PubMed, Springer Link, Science Direct, and Google Scholar databases. Articles that match the inclusion criteria were 415 articles and 408 articles were included in the exclusion criteria. After a critical appraisal was conducted, six articles were reviewed. This research was conducted in the period March-December 2020. The results of the study and analysis of six articles, there were three articles which stated that the administration of topical ciprofloxacin/dexamethasone was better than single topical ciprofloxacin, fluocinolone, and ofloxacin. One article stated that topical ciprofloxacin/dexamethasone was superior to oral amoxicillin/clavulanic acid in reducing clinical symptoms, but did not differ in microbiological eradication. In addition, there are two articles showing that administering topical ciprofloxacin has no different effect when compared to normal topical saline and cortisporin. The conclusion of this study was that topical ciprofloxacin/corticosteroid gave better results than other interventions, whereas topical ciprofloxacin alone gave an effect that was not significantly different from normal saline and topical cortisporin.

Key words: Acute otitis media, ototopical antibiotic, topical ciprofloxacin

Abstrak. Otitis media akut (OMA) adalah peradangan telinga tengah yang berlangsung hingga tiga minggu. Streptococcus pneumoniae dan Haemophilus influenza menyebabkan sekitar 50-90% kasus OMA.  Siprofloksasin topikal sering digunakan untuk mengobati OMA pada stadium perforasi. Tujuan penelitian ini adalah menganalisis efektivitas siprofloksasin topikal pada pasien OMA. Penelitian ini merupakan Scoping Review, dengan mencari artikel dari database PubMed, Springer Link, Science Direct, dan Google Scholar. Artikel yang sesuai dengan kriteria inklusi sebanyak 415 artikel dan yang termasuk dalam kriteria eksklusi sebanyak 408 artikel. Setelah dilakukan telaah kritis, artikel yang lolos sebanyak enam artikel. Penelitian ini dilakukan pada periode Maret-Desember 2020. Hasil telaah dan analisis enam artikel, terdapat tiga artikel yang menyatakan bahwa pemberian sediaan topikal siprofloksasin/deksametason lebih baik dibanding sediaan topikal siprofloksasin, fluokinolon, dan ofloksasin. Satu artikel menyatakan bahwa sediaan topikal siprofloksasin/deksametason lebih baik dibanding sediaan oral amoksisilin/asam klavulanat dalam mengurangi gejala klinisnya, namun tidak berbeda bermakna pada eradikasi mikrobiologis. Selain itu, terdapat dua artikel yang menunjukkan bahwa pemberian siprofloksasin topikal tidak memberikan efek yang berbeda ketika dibanding normal saline dan kortisporin topikal. Kesimpulan penelitian ini adalah siprofloksasin/kortikosteroid topikal memberikan hasil yang lebih baik daripada intervensi lain, sedangkan siprofloksasin topikal tunggal memberikan efek yang tidak berbeda dengan normal saline dan kortisporin topikal.

Kata kunci: Antibiotik ototopikal, otitis media akut, siprofloksasin topikal


Keywords


Antibiotik ototopikal, otitis media akut, siprofloksasin topikal

References


Wicaksana MA, Ratnawati LM, Andi K, Saputra D. Hubungan rinitis akut dan otitis media akut pada anak usia 012 tahun. Med Udayana [Internet]. 2019;8(6):2597–8012. Available from: https://ojs.unud.ac.id/index.php/eum

Ruohola A, Pettigrew MM, Lindholm L, Jalava J, Räisänen KS, Vainionpää R, et al. Bacterial and viral interactions within the nasopharynx contribute to the risk of acute otitis media. J Infect. 2013;66(3):247–54.

Utomo BS, Siregar FF. Profil klinis otitis media akut di Rumah Sakit Umum Universitas Kristen Indonesia. Maj Kedokt UKI. 2010;34(1):1–6.

Ilmyasri SA. Diagnosis dan tata laksana otitis media akut. J Penelit Perawat Prof [Internet]. 2020;2(4):473–482. Available from: http://jurnal.globalhealthsciencegroup.com/index.php/JPPP/article/download/83/65

Ubukata K, Morozumi M, Sakuma M, Takata M, Mokuno E, Tajima T, et al. Etiology of acute otitis media and characterization of pneumococcal isolates after introduction of 13-valent pneumococcal conjugate vaccine in Japanese children. Pediatr Infect Dis J. 2018;37(6):598–604.

Pettigrew MM, Gent JF, Pyles RB, Miller AL, Nokso-Koivisto J, Chonmaitree T. Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection. J Clin Microbiol. 2011;49(11):3750–5.

Carroll KC, Morse SA, Mietzner T, Miller S. Medical Microbiology. 27th ed. United States: McGraw-Hill Education; 2016.

Harmes KM, Blackwood RA, Burrows HL, Cooke JM, Van Harrison R, Passamani PP. Otitis media: Diagnosis and treatment. Am Fam Physician. 2013;88(7):435–40.

Venekamp RP, Prasad V, Hay AD. Are topical antibiotics an alternative to oral antibiotics for children with acute otitis media and ear discharge? BMJ. 2016;352(1):2–4.

Yang R, Sabharwal V, Okonkwo OS, Shlykova N, Tong R, Lin LY, et al. Treatment of otitis media by transtympanic delivery of antibiotics. Sci Transl Med. 2016;8(356):1–11.

Li Z, Hong H, Liao L, Ackley CJ, Schulz LA, MacDonald RA, et al. A mechanistic study of ciprofloxacin removal by kaolinite. Colloids Surfaces B Biointerfaces [Internet]. 2011;88(1):339–44. Available from: http://dx.doi.org/10.1016/j.colsurfb.2011.07.011

Hajji M, Jebali H, Mrad A, Blel Y, Brahmi N, Kheder R, et al. Nephrotoxicity of ciprofloxacin: Five cases and a review of the literature. Drug Saf - Case Reports [Internet]. 2018;5(1):1–5. Available from: https://doi.org/10.1007/s40800-018-0073-4

Kaguelidou F, Turner MA, Choonara I, Jacqz-Aigrain E. Ciprofloxacin use in neonates: A systematic review of the literature. Pediatr Infect Dis J. 2011;30(2):29–37.

Choi SH, Kim EY, Kim YJ. Systemic use of fluoroquinolone in children. Korean J Pediatr. 2013;56(5):196–201.

Gabarain G, Baird R, Morisada M, Anne S, Hopkins B. Early otorrhea rates: A randomized trial of ciprofloxacin versus saline drops after tympanostomy tubes. Ann Otol Rhinol Laryngol. 2019;128(8):760–6.

Spektor Z, Pumarola F, Ismail K, Lanier B, Hussain I, Ansley J, et al. Efficacy and safety of ciprofloxacin plus fluocinolone in otitis media with tympanostomy tubes in pediatric patients: A randomized clinical trial. JAMA Otolaryngol - Head Neck Surg. 2017;143(4):341–9.

Roland PS, Kreisler LS, Reese B, Anon JB, Lanier B, Conroy PJ, et al. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics. 2004;113(1):406.

Dohar J, Giles W, Roland P, Bikhazi N, Carroll S, Moe R, et al. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Pediatrics. 2006;118(3):5619.

Morpeth JF, Bent JP, Watson T. A comparison of cortisporin and ciprofloxacin otic drops as prophylaxis against post-tympanostomy otorrhea. Int J Pediatr Otorhinolaryngol. 2001;61(2):99–104.

Roland PS, Dohar JE, Lanier BJ, Hekkenburg R, Lane EM, Conroy PJ, et al. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes. Otolaryngol - Head Neck Surg. 2004;130(6):736–41.

Crowson MG, Schulz KC, Tucci DL. Provider and patient drivers of ototopical antibiotic prescription variability. Am J Otolaryngol - Head Neck Med Surg [Internet]. 2015;36(6):814–9. Available from: http://dx.doi.org/10.1016/j.amjoto.2015.07.001

Wang X, Fernandez R, Tsivkovskaia N, Harrop-Jones A, Hou HJ, Dellamary L, et al. OTO-201: Nonclinical assessment of a sustained-release ciprofloxacin hydrogel for the treatment of otitis media. Otol Neurotol. 2014;35(3):459–69.

Lorente J, Sabater F, Rivas MP, Fuste J, Risco J, Gómez M. Ciprofloxacin plus fluocinolone acetonide versus ciprofloxacin alone in the treatment of diffuse otitis externa. J Laryngol Otol. 2014;128(7):591–8.

Principi N, Bianchini S, Baggi E, Esposito S. No evidence for the effectiveness of systemic corticosteroids in acute pharyngitis, community-acquired pneumonia and acute otitis media. Eur J Clin Microbiol Infect Dis. 2013;32(2):151–60.

Zielnik-Jurkiewicz B, Bielicka A. Antibiotic resistance of Streptococcus pneumoniae in children with acute otitis media treatment failure. Int J Pediatr Otorhinolaryngol [Internet]. 2015;79(12):2129–33. Available from: http://dx.doi.org/10.1016/j.ijporl.2015.09.030

Schaefer P, Baugh RF. Acute otitis externa: an update. Am Fam Physician 2012; 86(11):1055–61.

Ranakusuma RW, Pitoyo Y, Safitri ED, Thorning S, Beller EM, Sastroasmoro S, et al. Systemic corticosteroids for acute otitis media in children. Cochrane Database Syst Rev. 2018;(3):139.

Qureishi A, Lee Y, Belfield K, Birchall JP, Daniel M. Update on otitis media-prevention and treatment. Infect Drug Resist J. 2014;7(1):15–24.

Jensen RG, Johansen HK, Bjarnsholt T, Eickhardt-Sørensen SR, Homøe P. Recurrent otorrhea in chronic suppurative otitis media: is biofilm the missing link? Eur Arch Oto-Rhino-Laryngol. 2017;274(7):2741–7.

Kim PJ, Attinger CE, Oliver N, Garwood C, Evans KK, Steinberg JS, et al. Comparison of outcomes for normal saline and an antiseptic solution for negative-pressure wound therapy with instillation. Plast Reconstr Surg. 2015;136(5):657e-664e.

Marchisio P, Santagati M, Scillato M, Baggi E, Fattizzo M, Rosazza C, et al. Streptococcus salivarius 24SMB administered by nasal spray for the prevention of acute otitis media in otitis-prone children. Eur J Clin Microbiol Infect Dis. 2015;34(12):2377–83.

Katzung BG, Trevor AJ. Basic and clinical pharmacology. 13th ed. United States: McGraw-Hill Education; 2015.

Berenholz LP, Rossi DL, Lippy WH, Burkey JM. Is there an ototoxicity risk from cortisporin and comparable otic suspensions? Distortion-product otoacoustic emission findings. Ear, Nose Throat J. 2012;91(3):106–13.




DOI: http://dx.doi.org/10.29313/kedokteran.v7i1.26559

Flag Counter